Mammalian Target of Rapamycin (mTOR) Signaling at the Crossroad of Muscle Fiber Fate in Sarcopenia

Int J Mol Sci. 2022 Nov 10;23(22):13823. doi: 10.3390/ijms232213823.

Abstract

The mammalian target of rapamycin (mTOR) is a major regulator of skeletal myocyte viability. The signaling pathways triggered by mTOR vary according to the type of endogenous and exogenous factors (e.g., redox balance, nutrient availability, physical activity) as well as organismal age. Here, we provide an overview of mTOR signaling in skeletal muscle, with a special focus on the role played by mTOR in the development of sarcopenia. Intervention strategies targeting mTOR in sarcopenia (e.g., supplementation of plant extracts, hormones, inorganic ions, calorie restriction, and exercise) have also been discussed.

Keywords: aging; atrogenes; autophagy; calorie restriction; mitophagy; neuromuscular junction; protein degradation; protein synthesis; rapalogs; skeletal muscle.

Publication types

  • Review

MeSH terms

  • Animals
  • Humans
  • Muscle Fibers, Skeletal / metabolism
  • Muscle, Skeletal / metabolism
  • Sarcopenia* / metabolism
  • Signal Transduction / physiology
  • Sirolimus
  • TOR Serine-Threonine Kinases / metabolism

Substances

  • MTOR protein, human
  • Sirolimus
  • TOR Serine-Threonine Kinases